Scancell appoints interim CFO as it hunts for permanent successor

2nd Apr 2026 12:05

(Sharecast News) - Scancell Holdings announced the appointment of David Schilansky as a financial adviser and incoming interim chief financial officer on Thursday, as current CFO Sath Nirmalananthan prepared to step down later this month.

The AIM-traded company said Schilansky would assume the interim CFO role later in April, bringing experience in biotech leadership and capital markets, including overseeing IPOs on Nasdaq and Euronext.

Nirmalananthan would leave the business and step down from the board on 24 April to pursue other opportunities, with Scancell initiating a global search for a permanent successor.

"David brings broad and strategic financing expertise to Scancell and will be a strong interim CFO, ensuring continuity and progress in our strategy," said chief executive Phil L'Huillier.

"We remain laser focused on delivering iSCIB1+ to patients and building shareholder value.

"Having David in place enables us to seamlessly advance our constructive financing and partnering discussions on our lead ImmunoBody iSCIB1+, now with the recently obtained strong regulatory feedback in hand.

"Further, David brings valuable investor engagement and strategic financing expertise, including Nasdaq listing experience that will help guide the company as we explore a potential listing in the US."

He added that Nirmalananthan had "played an important role at Scancell", providing "strong financial guidance" and preparing the company for its next phase of development.

"On behalf of the Scancell team, I would like to thank Sath for his dedicated and committed efforts to Scancell.

"We wish him all the best in his future endeavours."

Scancell said the appointment was intended to ensure continuity as it advanced its phase three trial of iSCIB1+, its lead ImmunoBody immunotherapy, while progressing financing and potential partnering discussions.

At 1130 BST, shares in Scancell Holdings were down 0.89% at 11.15p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate